Caring for a newborn is demanding for any parent, and it can be especially difficult for mothers experiencing postnatal depression. This condition not only affects maternal wellbeing but also can have lasting consequences for child development and psychiatric risk. A systematic review published in the January/February issue of Harvard Review of Psychiatry summarizes current evidence on how postnatal depression affects parenting and examines the emerging, but still uncertain, role of the hormone oxytocin in maternal behavior and mood.
Research synthesized in the review, led by Beth L. Mah, PhD, from the Mothers and Babies Research Centre at the Hunter Medical Research Institute in Australia, indicates that targeted interventions for women with postnatal depression can improve parenting practices and mother–infant interactions. The review also highlights both the potential and the unresolved questions around oxytocin therapy as an adjunct to these interventions.
Oxytocin, Postnatal Depression, and Parenting: Research Update
Postnatal depression is relatively common, affecting an estimated 10 to 20 percent of new mothers. When mothers experience ongoing depressive symptoms after childbirth, their infants face a higher risk of developmental delays and later psychiatric problems. The review examined 33 studies comparing parenting behaviors among mothers with and without postnatal depression. Across these studies, mothers with postnatal depression tended to engage less sensitively with their infants, reported lower parenting competence, and were less likely to use recommended practical parenting strategies.
Intervention studies varied in approach and outcome measures, but a consistent finding was that psychological treatments often yield measurable improvements in mother–infant interaction. These programs, which range from structured psychotherapy to parenting-skills training, suggest that improving maternal mood and parenting skills can positively affect the quality of caregiving.
Oxytocin—a neuropeptide well known for its roles in labor and breastfeeding—also appears to influence parenting behavior. The review identified 13 studies linking higher endogenous oxytocin levels with behaviors that foster bonding and sensitive caregiving. In many cases, oxytocin levels rose in mothers after affectionate, face-to-face contact with their infants, and higher natural oxytocin was associated with more nurturing parental responses. Some small trials have reported short-term improvements in parental behaviors after oxytocin administration, suggesting a potential therapeutic role.
However, the relationship between oxytocin and mood in the context of postnatal depression is complex and not yet clear. Only four studies to date directly examined oxytocin in relation to postnatal depression. Two observational studies found that lower oxytocin levels during pregnancy were associated with greater depressive symptoms. Contrastingly, two randomized trials—one involving women undergoing dysfunctional labor and another involving women with postnatal depression—reported increased depressive symptoms following oxytocin administration. These conflicting findings raise important safety and efficacy questions about using oxytocin as a treatment to improve maternal mood or parenting.
Given these mixed results, Dr. Mah emphasizes caution. While oxytocin may help improve certain parenting behaviors, its effects on maternal mood are uncertain and may differ between naturally occurring hormone levels and externally administered oxytocin. Before oxytocin can be recommended as part of treatment for mothers with postnatal depression, more rigorous research is needed to clarify its short- and long-term effects, appropriate dosing, and potential risks.
Key priorities for future research include stronger, more consistent methods for diagnosing postnatal depression and assessing parenting outcomes, standardized approaches to measuring oxytocin levels, and larger, well-controlled trials testing whether oxytocin can safely augment psychological and behavioral treatments. Establishing the safety profile of oxytocin in postpartum women is particularly important, given the preliminary evidence that administration may, in certain contexts, worsen mood symptoms.
In summary, the weight of evidence indicates that postnatal depression is linked to less sensitive parenting and reduced parental confidence, but that psychological and behavioral interventions can improve mother–infant interactions. Oxytocin shows promise for supporting bonding-related behaviors, yet its role as a therapeutic agent remains unresolved due to inconsistent findings about its impact on maternal mood. Determining whether oxytocin could serve as an effective and safe adjunct to existing treatments for mothers affected by postnatal depression represents an important challenge for future research.
Source: Connie Hughes – Wolters Kluwer Health
Image Source: The image is in the public domain
Original Research: Full open-access research: “Oxytocin, Postnatal Depression, and Parenting: A Systematic Review” by Beth L. Mah, PhD, published online January 2016 in Harvard Review of Psychiatry. doi:10.1097/HRP.0000000000000093
Abstract
Oxytocin, Postnatal Depression, and Parenting: A Systematic Review
Learning Objectives: After engaging with this review, readers should be better able to:
• Assess how postnatal depression affects parenting and early caregiver–infant interactions.
• Evaluate existing evidence on relationships between oxytocin levels and parental behaviors.
• Consider the potential role and limitations of oxytocin as an adjunct to interventions aimed at improving parenting.
Objective: To perform a systematic review exploring three interrelated questions: (1) How does postnatal depression influence parenting behavior? (2) How does oxytocin affect parenting? (3) What is the relationship between oxytocin and postnatal depression?
Methodology: The review examined English-language articles from major medical databases, focusing on studies that measured parenting behavior, depressive symptoms, and oxytocin levels or effects.
Results: Compared with nondepressed mothers, those with postnatal depression showed less sensitive interactions with their infants, lower self-reported parenting competence, and less frequent use of recommended parenting strategies. Psychological interventions generally improved mother–infant interactions. Administration of oxytocin in community samples often improved parental behaviors, but findings linking oxytocin and postnatal depression were inconsistent and included evidence that oxytocin administration might negatively affect mood in some contexts.
Conclusions: Oxytocin may hold promise for improving parenting behaviors among mothers with postnatal depression, but further high-quality research is required to confirm its safety and determine its impact on maternal mood before it can be recommended as a treatment adjunct.